Your browser doesn't support javascript.
loading
SP600125 has a remarkable anticancer potential against undifferentiated thyroid cancer through selective action on ROCK and p53 pathways.
Grassi, Elisa Stellaria; Vezzoli, Valeria; Negri, Irene; Lábadi, Árpád; Fugazzola, Laura; Vitale, Giovanni; Persani, Luca.
Afiliação
  • Grassi ES; DISCCO, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
  • Vezzoli V; DISCCO, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
  • Negri I; Laboratory of Endocrine and Metabolic Research, Istituto Auxologico Italiano IRCCS, Cusano Milanino, Italy.
  • Lábadi Á; Current address: IRIBHM, Institute of Interdisciplinary Research in Molecular Human Biology, Université Libre de Bruxelles, Brussels, Belgium.
  • Fugazzola L; Department of Laboratory Medicine, University of Pécs, Pécs, Hungary.
  • Vitale G; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
  • Persani L; Endocrine Unit-Fondazione IRCCS Ca' Granda, Milan, Italy.
Oncotarget ; 6(34): 36383-99, 2015 Nov 03.
Article em En | MEDLINE | ID: mdl-26415230

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article